Smart Pills Market Report 2026

Smart Pills Market Overview

• Smart Pills market size has reached to $6.11 billion in 2025 • Expected to grow to $10.13 billion in 2030 at a compound annual growth rate (CAGR) of 10.7% • Growth Driver: Growing Preference For Non-Invasive Procedures Increases Demand For Smart Pills • Market Trend: Rising Emphasis on Customizable Smart Pill Technologies to Strengthen Market Position • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Smart Pills Market?

Smart pills are used to deliver medication and are equipped with electronic sensors that emit signals to be captured by patches or smartphones when they are swallowed. These pills ensure drug regimen compliance and help track medication adherence of patients. The main applications of smart pills are capsule endoscopy, patient monitoring, and drug delivery, patient monitoring involves the repeated or continuous observations or measurements of the patient parameters. These pills are used to target the esophagus, stomach, small intestine, and large intestine to treat diseases such as esophageal diseases, colon diseases, small bowel diseases, and others. Smart pills are used by various end-users such as hospitals, diagnostic centres, and research institutes.

What Is The Smart Pills Market Growth Forecast?

The smart pills market size is expected to see rapid growth in the next few years. It will grow to $10.13 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to increasing demand for personalized medicine solutions, rising investments in digital therapeutics, expansion of remote patient monitoring, growing adoption of smart drug delivery platforms, increasing regulatory support for connected health technologies. Major trends in the forecast period include increasing adoption of sensor-enabled drug delivery systems, rising focus on medication adherence solutions, growing integration with mobile health platforms, expansion of smart ingestible diagnostics, enhanced development of miniaturized electronics.

Global Smart Pills Market Segmentation

1) By Target Area: Esophagus, Stomach, Small Intestine, Large Intestine 2) By Disease Indication: Esophageal Diseases, Colon Diseases, Small bowel Diseases, And Other Disease Indications 3) By Application: Capsule Endoscopy, Patient Monitoring, Drug Delivery 4) By End User: Hospital, Diagnostic Center, Research Institute Subsegments: 1) By Esophagus: Diagnostic Pills For Esophageal Disorders, Pills For Monitoring Esophageal Motility 2) By Stomach: Gastric Emptying Monitoring Pills, Diagnostic Pills For Gastric Disorders 3) By Small Intestine: Pills For Absorption Studies, Diagnostic Pills For Small Bowel Diseases 4) By Large Intestine: Colonoscopy Alternative Pills, Pills For Detecting Colorectal Disorders

What Are The Drivers Of The Smart Pills Market?

The growing preference for non-invasive procedures is expected to propel the growth of the smart pills market going forward. Non-invasive procedures avoid incisions or tissue removal and therefore reduce patient risk and recovery time. The growing preference for non-invasive procedures is due to their ability to deliver effective diagnostic and therapeutic outcomes while minimizing physical burden on patients. Smart pills support non-invasive procedures by enabling internal imaging and physiological monitoring without surgical entry, allowing clinicians to gather diagnostic data through a simple swallowable device. For instance, in March 2024, according to NHS England, a UK-based public health service, more than 5,400 patients benefited from colon capsule endoscopy pill-cam pilots across 53 sites. Therefore, the growing preference for non-invasive procedures is driving the smart pills industry. The growing healthcare expenditure is expected to propel the growth of the smart pills market going forward. Healthcare expenditure refers to the total amount of money spent on medical services, treatments, facilities, research, and public health initiatives to maintain or improve health outcomes. The increasing demand for healthcare expenditure is due to the rising prevalence of chronic mental health conditions, which require continuous treatment, medication, and long-term care support. Healthcare expenditure supports the development of smart pills by funding advanced technologies that enhance drug delivery, monitoring, and patient adherence. For instance, in December 2024, according to the Centers for Medicare and Medicaid Services (CMS), a US-based federal agency, the national health expenditures (NHE) grew by 7.5% to $4.9 trillion in 2023, accounting for 17.6% of gross domestic product (GDP). Additionally, between 2023 and 2032, average national health expenditures (NHE) are projected to grow at an average annual rate of 5.6%, resulting in an increase in the health spending share of gross domestic product (GDP) from 17.3% in 2022 to 19.7% in 2032. Therefore, the growing healthcare expenditure is driving the growth of the smart pills industry.

Key Players In The Global Smart Pills Market

Major companies operating in the smart pills market are Medtronic plc, Olympus Corporation, CapsoVision Inc., Novartis AG, Proteus Digital Health Inc., Koninklijke Philips N.V., MicroCHIPS Inc., Bio-Images Drug Delivery (BDD) Ltd., Given Imaging Ltd., Vitality Inc., Boston Scientific Corporation, HQ Inc., Fujifilm Holdings Corporation, General Electric Company, Check-Cap Ltd., IntroMedic Co. Ltd., Jinshan Science & Technology Co. Ltd., PENTAX Medical, etectRx Inc., Pixie Scientific HQ Inc., ANX Robotica Corp., RF Co. Ltd., Shenzhen Jifu Medical Technology Co. Ltd., Otsuka America Pharmaceutical Inc., Medimetrics Personalized Drug Delivery B.V., Smart Pill Inc., Medisafe Inc., AdhereTech LLC, TabSafe Medical Services Inc.

Global Smart Pills Market Trends and Insights

Major companies operating in the smart pills market are focusing on developing smart pills with customizable programs, such as ingestible, multi-sensor prototypes that enable tailored drug delivery and in-vivo monitoring to improve treatment adherence and therapeutic outcomes. Customizable programs refer to firmware or software-driven control of sensing, data collection, and triggerable actions that clinicians or trial managers can configure for individual patients. For instance, in 2025, Interuniversity Microelectronics Centre, a Belgium-based research and innovation institute, introduced a prototype ingestible sensor for gut-health monitoring that integrates multiple sensing modalities (chemical, mechanical and electrical), on-board signal processing and power management, and real-time data transmission capability for remote monitoring; the prototype emphasizes miniaturization and full-system integration to enable configurable sensing programs for personalized clinical use.

Regional Outlook

North America was the largest region in the smart pills market in 2025. Western Europe was the second-largest region in the smart pills market analysis. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Smart Pills Market?

The smart pills market consists of sales of instruments that are used in applications such as capsule endoscopy, drug delivery, and patient monitoring. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.